CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
GNLN
Greenlane Holdings, Inc.
There isn't enough reported data to score GNLN yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
GNLN Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
GNLN's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | โ |
| Current | 35x | $31.89 | โ |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
GNLN PE Valuation
GNLN has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
GNLN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect GNLN's losses to grow, with revenue growing.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the stronger earnings trend. Trailing diluted EPS is up 718% for CELH versus GNLN down 101%.
GNLN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$13,612,407.60 | +$13,711,592.40 |
| Q2 2022 | -$11,480,607.60 | +$15,051,392.40 |
| Q1 2022 | -$12,094,407.60 | +$14,701,592.40 |
| Q4 2021 | -$13,546,407.60 | +$15,229,592.40 |
GNLN lost $84,180.00 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over GNLN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over GNLN on profitability, with a higher operating margin.
GNLN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $82K | -90% |
| Q1 2026 | $448K | -70% |
| Q4 2025 | $1.4M | -18% |
| Q3 2025 | $737K | -82% |
| Q2 2025 | $788K | -70% |
| Q1 2025 | $1.5M | -70% |
| Q4 2024 | $1.7M | -83% |
| Q3 2024 | $4M | -66% |
GNLN's revenue has slid since its 2021 peak: $82,000 last quarter, down 90% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4005% | -3592 points |
| Q1 2026 | -1244% | -1007 points |
| Q4 2025 | -2835% | -2606 points |
| Q3 2025 | -1235% | -1221 points |
| Q2 2025 | -413% | -281 points |
| Q1 2025 | -237% | -156 points |
| Q4 2024 | -229% | -199 points |
| Q3 2024 | -13% | +45 points |
GNLN's operating margin was โ4005% last quarter, down 3592 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with GNLN at up 35%.
GNLN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$4.5M | -$2.9M |
| Q3 2025 | -$3.9M | +$961K |
| Q2 2025 | -$452K | -$138K |
| Q1 2025 | -$3.5M | -$3.2M |
| Q4 2024 | -$1.6M | +$1.8M |
| Q3 2024 | -$4.9M | -$1.1M |
| Q2 2024 | -$314K | -112% |
| Q1 2024 | -$216K | -113% |
GNLN has burned cash in almost every quarter: โ$12M over the past year, against โ$7M the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
GNLN Net Leverage
GNLN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
GNLN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.0 | Oversold |
| Stochastic | 2.4 | Oversold |
GNLN's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
GNLN PE vs Consumer Defensive Sector
GNLN has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over GNLN on trend strength, trading above more of its moving averages.
GNLN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.04 | 52% below |
| 20 week MA | $2.27 | 57% below |
| 50 week MA | $5.75 | 83% below |
| 100 week MA | $1,051.6 | 100% below |
| 200 week MA | $39,698.9 | 100% below |
GNLN is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over GNLN on returns for 2026, with the stronger performance.
GNLN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42,240,000.0 | $54,648,000.0 | +29% |
| 2021 | $54,648,000.0 | $13,464,000.0 | -75% |
| 2022 | $13,464,000.0 | $200,910.6 | -99% |
| 2023 | $200,910.6 | $34,188.7 | -83% |
| 2024 | $34,188.7 | $9,600.0 | -72% |
| 2025 | $9,600.0 | $16.9 | -100% |
| 2026 YTD | $16.9 | $0.97 | -94% |
GNLN has finished five years in a row lower, and it's down 94% so far in 2026.